ArticleJournal of orthopaedic case reports2025
Giant Cell Tumor of the Proximal Femur with Pathological Fracture of Femoral neck.
Article in Journal of orthopaedic case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Giant cell tumor (GCT) of bone is a locally aggressive, benign neoplasm, accounting for approximately 20% of all bone tumors. While the distal femur and proximal tibia are the most common locations for GCTs, with the majority arising in the epiphyseal regions, their occurrence in the proximal femur is relatively rare, representing only 5.5% of cases. These tumors pose significant management challenges due to their tendency to cause pathological fractures, aggressive local behavior, and involvement of critical weight-bearing bones. Effective treatment requires careful consideration of both oncological control and functional preservation. Case Report: A 43-year-old male presented with a GCT in the proximal femur, complicated by a pathological fracture of the femoral neck. Given the tumor's size and location, the patient underwent extended curettage (EC) to remove the tumor, followed by internal fixation with a dynamic hip screw and the application of bone cement for additional stabilization. Post-operative monitoring, including clinical and radiological assessments, showed favorable results. After a 12-month follow-up period, the patient had no signs of recurrence, and his functional and radiological outcomes were excellent, with restored mobility and the ability to bear weight on the affected limb. Conclusion: This case emphasizes the need for a tailored treatment strategy when managing GCTs of the proximal femur, particularly in resource-limited settings. The combination of EC, internal fixation, and bone cement was effective in achieving both oncological control and functional recovery. Long-term follow-up remains essential to monitor for recurrence and to ensure the integrity of the fixation device. The positive outcomes in this case highlight the potential for successful management of GCTs in challenging anatomical locations with appropriate surgical intervention and post-operative care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.